Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+thalassemia with IVS1-5(G→C) mutation

Title
Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+thalassemia with IVS1-5(G→C) mutation
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 62, Issue 6, Pages 1017-1023
Publisher
Wiley
Online
2014-12-25
DOI
10.1002/pbc.25391

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started